Thermo Fisher Scientific has expanded its bioprocess design center network across Asia, adding a new facility in Hyderabad, India, and enlarging existing centers in Incheon, Korea, and Singapore. The bioprocess design center investments reflect rapid regional growth in biologics and advanced therapies and provide biopharma teams with localized access to bioprocessing capabilities, specialized expertise, and infrastructure to accelerate development. For laboratory managers supporting bioprocess workflows or technology evaluations, the expansion highlights an industry shift toward regionalized support models that reduce scale-up risk and enable more direct collaboration.
New bioprocess design centers expand regional support
Thermo Fisher’s tri-hub network connects bioprocess design centers in Incheon, Hyderabad, and Singapore, each designed to strengthen biomanufacturing by providing hands-on access to advanced tools and process development environments. Incheon’s expanded center adds upgraded lab capabilities, new collaboration areas, and access to advanced materials and technologies. The Hyderabad center, developed with the Government of Telangana, offers simulation and optimization spaces where teams can co-create and test bioprocesses using single-use and hybrid systems. The Singapore site provides bench-to-pilot-scale capacity and expert-led training to help teams refine early-stage workflows and prepare for technology transfer.
How new capabilities support biomanufacturing
By distributing bioprocess design infrastructure across three hubs, Thermo Fisher aims to shorten development timelines and offer more agile technical support. The centers integrate analytical systems, advanced bioprocessing platforms, and characterization tools to help organizations address bottlenecks from upstream development through early commercialization. According to the company, this network is intended to help customers deliver biologics more efficiently, cost-effectively, and sustainably across diverse regional markets.
How bioprocess design centers support lab decision-making
The expanded bioprocess design center network offers laboratory managers practical advantages that extend beyond biomanufacturing. These hubs provide controlled environments where teams can assess single-use technologies, evaluate hybrid system performance, and refine critical process parameters before committing to capital purchases. Early access to pilot-scale testing can reduce variability during technology transfer, improve readiness for qualification activities, and strengthen documentation workflows that support quality management.
Hands-on training at the centers also helps laboratory teams build operational competence in emerging bioprocessing platforms, which can streamline onboarding, reduce procedural errors, and improve consistency across shifts or sites. For labs operating within global organizations, localized support in Asia can shorten troubleshooting cycles, accelerate adoption of new analytical methods, and improve alignment among R&D, process development, and manufacturing groups. Collectively, these advantages help laboratory managers make informed decisions about instrumentation, workflow design, staffing needs, and long-term scalability.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
